Prospective observational study finds AI concordance in detecting DRPs in hematology, suggesting collaboration enhances outcomes.
Introduction Large language models (LLMs) offer potential as clinical decision support systems (CDSS) for detecting drug-related problems (DRPs), yet their real-world performance compared to clinical pharmacists (CPs) remains unclear, especially in complex hematology care. We aimed to evaluate the concordance between a clinical pharmacist and three LLMs in identifying DRPs within a Bone Marrow Transplantation unit. Methods This prospective observational study evaluated the concordance between a CP and three LLMs (ChatGPT-4o, Grok-3, DeepSeek-v3) in a Bone Marrow Transplantation unit. Eighty-three anonymized patient cases encompassing 210 CP-identified DRPs, classified via the PCNE v9.1 system, were presented using a standardized CDSS-simulating prompt. Performance was assessed based on direct detection, prompted detection after structured follow-up, and the clinical relevance of AI-generated therapeutic recommendations against the CP's gold-standard assessments. Results Direct detection of intervention-requiring DRPs was limited (51.4%-60.5% across models), with nearly half missed initially. Guided prompting significantly improved overall detection rates to 93.8%-98.1%, with ChatGPT achieving the highest accuracy. All models produced hallucinations. Recommendation concordance with the CP exceeded 70% in most DRP categories. DeepSeek and ChatGPT showed more consistent performance in context-dependent evaluations, whereas Grok demonstrated higher direct detection but lower recommendation alignment. LLMs demonstrate meaningful potential to assist in DRP detection but are not sufficiently reliable as standalone tools. Expert-guided interaction substantially enhanced their performance, underscoring the critical value of hybrid pharmacist-AI workflows. Conclusion Future research should validate these findings across broader populations with multiple expert evaluators and integrate next-generation AI architectures for safer CDSS implementation.
No takes yet. Share an insight, caveat, or question.
Demirpolat et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: